marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Ovid Therapeutics Cash Flow 2011-2024 | OVID
Annual Cash Flow Ovid Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-45.8 M | -55.2 M | 119 M | -51.6 M | -51.1 M | -45.6 M | -31.5 M | - | - | - | - | - | - |
Depreciation & Amortization |
568 K | 513 K | 237 K | 307 K | 255 K | 142 K | 80.3 K | 56.5 K | 11.8 K | - | - | - | - |
Accounts Payables |
3.7 M | 1.95 M | 7.13 M | 5.45 M | 3.26 M | 3.76 M | 2.03 M | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Ovid Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -16.7 M | - | - | - | -12.1 M | - | -46.1 M | -33.4 M | -20.1 M | - | 131 M | 141 M | 161 M | - | -37.1 M | -35.6 M | -18.4 M | - | -34.2 M | -24.7 M | -12.9 M | - | -34.6 M | -24.5 M | -12.9 M | - | -22.5 M | -13.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
105 K | 103 K | 136 K | - | 104 K | 105 K | 145 K | - | 102 K | 54.6 K | 73.8 K | - | 180 K | 128 K | 74.7 K | - | 224 K | 145 K | 66.9 K | - | 201 K | 146 K | 76.5 K | - | 86.4 K | 51.7 K | 26.4 K | - | 58.6 K | 37.6 K | 18.5 K | - | 23.8 K | 14.6 K | 5.9 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
2.71 M | 4.72 M | 3.6 M | 3.7 M | 1.22 M | 3.76 M | 1.83 M | 1.95 M | 1.03 M | 4.62 M | 2.26 M | 7.13 M | 3.14 M | 910 K | 3.15 M | 5.45 M | 5.45 M | 5.45 M | 5.45 M | 3.26 M | 3.26 M | 3.26 M | 3.26 M | 3.76 M | 3.76 M | 3.76 M | 3.76 M | 2.03 M | 2.03 M | 2.03 M | 2.03 M | 857 K | 857 K | 857 K | 857 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency